RICHMOND HILL, ON, Sept. 17 /CNW/ - Ajanta Pharma has entered into an in-licensing agreement with Prollenium Medical Technologies of Canada and will have exclusive marketing rights for Prollenium’s highly successful dermal filler ‘Revanesse(R)’ in India.
